New hope for treating the toughest cancers

December 20, 2022

The Mays Cancer Center at UT Health San Antonio — South Texas’ only National Cancer Institute-Designated Cancer Center — is putting a decades-old antidepressant drug to new use treating breast cancers that don’t respond to existing therapies. Research in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio provided […]

Ratna Vadlamudi, PhD, lab group

Living Beyond Cancer symposium scheduled for January

December 13, 2022

  Cancer survivors, cancer patients, friends, family and caregivers are invited to attend Living Beyond Cancer A-Z, a free symposium on Jan. 21, put on by the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center. It will feature a full day of learning, empowerment and discovery and will take place […]

Findings on oral drug to be presented at San Antonio Breast Cancer Symposium

November 30, 2022

Elacestrant may improve care of metastatic ER+/HER2- tumors Contact: Will Sansom, 210-567-2579, SAN ANTONIO (Nov. 30, 2022) — Phase III results of EMERALD, a clinical trial evaluating a novel oral drug therapy for metastatic ER-positive/HER2-negative (ER+/HER2-) breast cancer, will be presented Thursday, Dec. 8, at the San Antonio Breast Cancer Symposium (SABCS). Virginia Kaklamani, MD, […]

Dr. Virginia Kaklamani

CPRIT adds $10.9 million to UT Health San Antonio cancer research and prevention efforts

February 17, 2022

Contact: Will Sansom, (210) 567-2579, SAN ANTONIO (Feb. 17, 2022) — The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is receiving $10.9 million in new research and faculty recruitment awards announced Feb. 16 by the Cancer Prevention and Research Institute of Texas (CPRIT). The statewide cancer agency has […]

Concept Art of a Microscope